Xcout IntelImplicit Bioscience Inc
Implicit Bioscience, Inc. is a biotechnology company founded in 2002 that focuses on the clinical development of novel immunotherapies and treatments for critical illnesses.
Subscribe to see Implicit Bioscience Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Implicit Bioscience Inc at a glance
Implicit Bioscience Inc is a biotechnology company headquartered in Australia. It has raised at least $818,643 across the 5 funding rounds on record. Its most recent funding round raised $65,551 in August 2020. Xcout tracks 14 named people at Implicit Bioscience Inc, including Garry Redlich (CEO & MD).
Implicit Bioscience Inc leadership
- Garry RedlichCEO & MD
- Jan AgostiChief Medical Officer
- Peter AndrewsChairman
- Brian ZiegelaarVP AU Ops
- David CroweVP Research
- Mark ApplebyVP Preclinical
8 more named people on record for Implicit Bioscience Inc, with roles, board committees and tenure — see the full roster →
Implicit Bioscience Inc funding rounds
At least $818,643 raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $65,551 | — | |
| SEC Form D filing | $367,227 | — | |
| SEC Form D filing | $125,000 | — | |
| SEC Form D filing | $210,065 | — | |
| SEC Form D filing | $50,800 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Implicit Bioscience Inc competitors
A few of Implicit Bioscience Inc's closest competitors — see the full list of competitors and alternatives →
ImmPACT Bio USA, Inc. is a clinical-stage biotechnology company headquartered in West Hills, California. The company focuses on developing advanced cell therapies and immunotherapies to treat cancer and other serious diseases.
ImmPACT Bio is a biotechnology company developing next-generation cancer immunotherapies, including dual-targeted CAR T-cell therapies. Its programs are intended to serve patients with B-cell malignancies and potentially other cancers, including solid tumors.
Sensei Biotherapeutics, Inc. is a clinical stage biotechnology company focused on the discovery and development of new therapies.
Immunomic Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company founded in 2005 and headquartered in Rockville, Maryland, that develops innovative immune therapies.
Amplica Bio, Inc. is a biotechnology company that develops next-generation biologics and therapies aimed at targeting difficult diseases. The company engages in drug engineering to address challenging therapeutic targets.
Impact BioMedical Inc. is a pioneering biotechnology company incorporated in 2018 and based in Houston, Texas, dedicated to discovering, developing, and patenting innovative healthcare products, drug pipelines, and technology platforms.
Get Implicit Bioscience Inc's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Implicit Bioscience Inc in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access